CMMB
Chemomab Therapeutics
CMMB
CMMB
9 hedge funds and large institutions have $2.28M invested in Chemomab Therapeutics in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
56% less capital invested
Capital invested by funds: $5.22M → $2.28M (-$2.94M)
Holders
9
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$46.3K | |
| 2 | +$39.7K | |
| 3 | +$33.1K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$972 |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$972 |
Top Sellers
| 1 | -$448K | |
| 2 | -$233K | |
| 3 | -$214K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$23.1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$6K |